A Yoga Program for Breast Cancer Patients Undergoing Chemotherapy
| Status: | Completed |
|---|---|
| Conditions: | Insomnia Sleep Studies, Other Indications |
| Therapuetic Areas: | Psychiatry / Psychology, Other |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 2/13/2019 |
| Start Date: | April 2014 |
| End Date: | December 5, 2018 |
A Yoga Program for Breast Cancer Patients Undergoing Chemotherapy: Effects on Quality of Life and Chemotherapy-associated Symptoms
The primary aim of this study is to assess and compare change in QOL during chemotherapy as
measured by the Functional Assessment of Cancer Therapy-Breast (FACT-Breast) score between
patients receiving yoga and those not receiving yoga. Secondary endpoints will include other
measures of QOL such as sleep quality measured with the Pittsburg Sleep Quality Inventory
(PSQI), anxiety and depression using Hospital Anxiety and Depression Scale (HADS), and
adherence to yoga and to chemotherapy treatment.
measured by the Functional Assessment of Cancer Therapy-Breast (FACT-Breast) score between
patients receiving yoga and those not receiving yoga. Secondary endpoints will include other
measures of QOL such as sleep quality measured with the Pittsburg Sleep Quality Inventory
(PSQI), anxiety and depression using Hospital Anxiety and Depression Scale (HADS), and
adherence to yoga and to chemotherapy treatment.
Inclusion Criteria:
- Age>18 years
- History of stage I-III breast cancer
- Patient scheduled to receive or within 2 weeks of receiving intravenous chemotherapy
for their breast cancers
- Eastern Cooperative Oncology Group Performance status of <3
- Ability to understand English
5.2 Exclusion Criteria:
- Planning to start yoga on their own within the next 12 weeks
- Maintained a regular personal practice or yoga within the 3 months before enrolling
onto the study
- Severe chronic obstructive pulmonary disease
- Class III or IV heart failure
- Child C cirrhosis
- End-Stage renal disease
Exclusion Criteria:
- Planning to start yoga on their own within the next 12 weeks
- Maintained a regular personal practice or yoga within the 3 months before enrolling
onto the study
- Severe chronic obstructive pulmonary disease
- Class III or IV heart failure
- Child C cirrhosis
- End-Stage renal disease
We found this trial at
1
site
305 1st Avenue # Dazian 7
New York, New York 10003
New York, New York 10003
(212) 420-2806
Principal Investigator: Theresa Shao, MD
Phone: 212-367-0186
Beth Israel Med Ctr The physicians and staff of Mount Sinai Beth Israel's Heart Institute...
Click here to add this to my saved trials
